Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theranostics

Showing results (1191-1200 of 5,510) with videos related to

Pageof 551
Sort By:
Theranostics|August 9, 2023
Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signalingBo Qian, Lin Che, Ze-Bang Du, et al.
Theranostics|August 9, 2023
OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer TreatmentShiyu Liu, Fan Li, Qiongqiong Ma, et al.
Theranostics|January 2, 2024
Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatmentsSusan Richter, Charlotte Steenblock, Alessa Fischer, et al.
Theranostics|January 3, 2024
Initial IL-10 production dominates the therapy of mesenchymal stem cell scaffold in spinal cord injuryLijun Yang, Jian Cao, Yiwen Du, et al.
Theranostics|January 3, 2024
Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumorsKeshuang Zheng, Yongpu Feng, Lei Li, et al.
Theranostics|January 2, 2024
The LMIT: Light-mediated minimally-invasive theranostics in oncologyYingwei Fan, Shuai Liu, Enze Gao, et al.
Theranostics|January 2, 2024
Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapyDongdong Tang, Yang Yan, Yangyang Li, et al.
Theranostics|January 2, 2024
Imaging diagnosis and efficacy monitoring by [<sup>89</sup>Zr]Zr-DFO-KN035 immunoPET in patients with PD-L1-positive solid malignanciesHuihui He, Xiaowei Qi, Haitian Fu, et al.
Theranostics|January 2, 2024
Vitamin D binding protein (VDBP) hijacks twist1 to inhibit vasculogenic mimicry in hepatocellular carcinomaLu-Ning Qin, Heng Zhang, Qing-Qing Li, et al.
Theranostics|January 2, 2024
Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs)Richard P Baum, Peipei Wang, Vivianne Jakobsson, et al.
Pageof 551

Showing results (1191-1200 of 5,510) with videos related to

Sort By:
Pageof 551
Theranostics|August 9, 2023
Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signalingBo Qian, Lin Che, Ze-Bang Du, et al.
Theranostics|August 9, 2023
OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer TreatmentShiyu Liu, Fan Li, Qiongqiong Ma, et al.
Theranostics|January 2, 2024
Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatmentsSusan Richter, Charlotte Steenblock, Alessa Fischer, et al.
Theranostics|January 3, 2024
Initial IL-10 production dominates the therapy of mesenchymal stem cell scaffold in spinal cord injuryLijun Yang, Jian Cao, Yiwen Du, et al.
Theranostics|January 3, 2024
Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumorsKeshuang Zheng, Yongpu Feng, Lei Li, et al.
Theranostics|January 2, 2024
The LMIT: Light-mediated minimally-invasive theranostics in oncologyYingwei Fan, Shuai Liu, Enze Gao, et al.
Theranostics|January 2, 2024
Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapyDongdong Tang, Yang Yan, Yangyang Li, et al.
Theranostics|January 2, 2024
Imaging diagnosis and efficacy monitoring by [<sup>89</sup>Zr]Zr-DFO-KN035 immunoPET in patients with PD-L1-positive solid malignanciesHuihui He, Xiaowei Qi, Haitian Fu, et al.
Theranostics|January 2, 2024
Vitamin D binding protein (VDBP) hijacks twist1 to inhibit vasculogenic mimicry in hepatocellular carcinomaLu-Ning Qin, Heng Zhang, Qing-Qing Li, et al.
Theranostics|January 2, 2024
Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs)Richard P Baum, Peipei Wang, Vivianne Jakobsson, et al.
Pageof 551